Flagship Pioneering, LLC Long-Term Concentrated

Location: Cambridge, MA

CIK: 0001400240 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $4.259B (100.0% shares, 0.0% debt)

Holdings (13)

MRNA Moderna Inc 71.1%

Value $3.029B Shares 17,581,016 Est. Cost $16.43 Unrealized +924.4%

SANA Sana Biotechnology Inc 6.6%

Value $283M Shares 34,239,018 Est. Cost $32.56 Unrealized -75.2%

— Rubius Therapeutics Inc 5.0%

Value $212M Shares 38,506,526 Est. Cost $24.00 Unrealized —

FHTX Foghorn Therapeutics Inc 4.5%

Value $193M Shares 12,674,120 Est. Cost $19.16 Unrealized -28.4%

— Omega Therapeutics Inc 3.8%

Value $162M Shares 25,902,269 Est. Cost $18.85 Unrealized —

— Seres Therapeutics Inc 2.4%

Value $102M Shares 14,378,802 Est. Cost $8.55 Unrealized —

DNLI Denali Therapeutics Inc 2.0%

Value $84.28M Shares 2,619,968 Est. Cost $17.97 Unrealized +91.5%

— Evelo Biosciences Inc 1.8%

Value $78.07M Shares 23,030,069 Est. Cost $10.39 Unrealized —

— Axcella Health Inc 1.1%

Value $48.49M Shares 18,867,785 Est. Cost $6.29 Unrealized —

KLDO Kaleido Biosciences Inc 0.8%

Value $32.3M Shares 19,575,710 Est. Cost $13.01 Unrealized -86.3%

— Codiak Biosciences Inc 0.4%

Value $16.35M Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Sigilon Therapeutics Inc 0.4%

Value $15.24M Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Syros Pharmaceuticals Inc 0.1%

Value $3.497M Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	17,581,016	$3.029B	71.1%	$16.43	+924.4%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$283M	6.6%	$32.56	-75.2%	COM	799566104
—	Rubius Therapeutics Inc	38,506,526	$212M	5.0%	$24.00	—	COM	78116T103
FHTX	Foghorn Therapeutics Inc	12,674,120	$193M	4.5%	$19.16	-28.4%	COM	344174107
—	Omega Therapeutics Inc	25,902,269	$162M	3.8%	$18.85	—	COM	68217N105
—	Seres Therapeutics Inc	14,378,802	$102M	2.4%	$8.55	—	COM	81750R102
DNLI	Denali Therapeutics Inc	2,619,968	$84.28M	2.0%	$17.97	+91.5%	COM	24823R105
—	Evelo Biosciences Inc	23,030,069	$78.07M	1.8%	$10.39	—	COM	299734103
—	Axcella Health Inc	18,867,785	$48.49M	1.1%	$6.29	—	COM	05454B105
KLDO	Kaleido Biosciences Inc	19,575,710	$32.3M	0.8%	$13.01	-86.3%	COM	483347100
—	Codiak Biosciences Inc	2,607,303	$16.35M	0.4%	$32.30	—	COM	192010106
—	Sigilon Therapeutics Inc	10,370,369	$15.24M	0.4%	$48.03	—	COM	82657L107
—	Syros Pharmaceuticals Inc	2,938,494	$3.497M	0.1%	$13.87	—	COM	87184Q107